Avantax Planning Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,363
Closed -$236K 468
2024
Q2
$236K Sell
3,363
-311
-8% -$22.2K 0.01% 405
2024
Q1
$272K Buy
+3,674
New +$256K 0.01% 379
2018
Q4
Sell
-2,676
Closed -$125K 833
2018
Q3
$125K Buy
+2,676
New +$122K 0.01% 302
2018
Q2
Sell
-2,712
Closed -$124K 964
2018
Q1
$124K Buy
+2,712
New +$132K 0.01% 371
2017
Q4
Sell
-6,242
Closed -$324K 337
2017
Q3
$324K Sell
6,242
-762
-11% -$37.1K 0.03% 259
2017
Q2
$343K Buy
7,004
+117
+2% +$5.43K 0.03% 234
2017
Q1
$324K Sell
6,887
-1,096
-14% -$52.3K 0.03% 231
2016
Q4
$383K Buy
+7,983
New +$366K 0.04% 198

Other funds holding MET

Avantax Planning Partners's MET Position: Q3 2024 in Review

Avantax Planning Partners sold out of MetLife (MET) in Q3 2024, closing a stake of 3,363 shares — an estimated $236K sold.

Avantax Planning Partners first reported a position in MET in Q4 2016 and held it in 8 quarters. The position peaked at $383K in Q4 2016. 1,318 funds tracked by Wall St. Rank hold MET as of Q3 2024.

  • Avantax Planning Partners reported no remaining MetLife position as of Q3 2024 after selling out during the quarter.
  • Avantax Planning Partners sold 3,363 MetLife shares in Q3 2024, an estimated $236K.
  • Avantax Planning Partners first reported a position in MetLife in Q4 2016 and held it in 8 quarters.
  • Avantax Planning Partners's MetLife position peaked at $383K in Q4 2016.
  • 1,318 funds tracked by Wall St. Rank held MetLife as of Q3 2024.

Based on Avantax Planning Partners's 13F filing for Q3 2024, filed 14 Nov 2024.